AU2011274245B2 - Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease - Google Patents

Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease Download PDF

Info

Publication number
AU2011274245B2
AU2011274245B2 AU2011274245A AU2011274245A AU2011274245B2 AU 2011274245 B2 AU2011274245 B2 AU 2011274245B2 AU 2011274245 A AU2011274245 A AU 2011274245A AU 2011274245 A AU2011274245 A AU 2011274245A AU 2011274245 B2 AU2011274245 B2 AU 2011274245B2
Authority
AU
Australia
Prior art keywords
contact lens
dexpanthenol
panthenol
composition
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011274245A
Other languages
English (en)
Other versions
AU2011274245A1 (en
Inventor
Brien Anthony Holden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brien Holden Vision Institute Ltd
Original Assignee
Brien Holden Vision Institute Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010902954A external-priority patent/AU2010902954A0/en
Application filed by Brien Holden Vision Institute Ltd filed Critical Brien Holden Vision Institute Ltd
Priority to AU2011274245A priority Critical patent/AU2011274245B2/en
Publication of AU2011274245A1 publication Critical patent/AU2011274245A1/en
Application granted granted Critical
Publication of AU2011274245B2 publication Critical patent/AU2011274245B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2011274245A 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease Ceased AU2011274245B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2011274245A AU2011274245B2 (en) 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2010902954A AU2010902954A0 (en) 2010-07-02 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
AU2010902954 2010-07-02
AU2011274245A AU2011274245B2 (en) 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
PCT/AU2011/000827 WO2012000055A1 (en) 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Publications (2)

Publication Number Publication Date
AU2011274245A1 AU2011274245A1 (en) 2013-01-10
AU2011274245B2 true AU2011274245B2 (en) 2014-07-17

Family

ID=45401233

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011274245A Ceased AU2011274245B2 (en) 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Country Status (9)

Country Link
US (2) US9161923B2 (cg-RX-API-DMAC7.html)
EP (1) EP2588096A4 (cg-RX-API-DMAC7.html)
JP (1) JP2013534527A (cg-RX-API-DMAC7.html)
CN (1) CN103037858A (cg-RX-API-DMAC7.html)
AU (1) AU2011274245B2 (cg-RX-API-DMAC7.html)
CA (1) CA2803935A1 (cg-RX-API-DMAC7.html)
SG (1) SG186782A1 (cg-RX-API-DMAC7.html)
TW (1) TW201206418A (cg-RX-API-DMAC7.html)
WO (1) WO2012000055A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
CN103037858A (zh) * 2010-07-02 2013-04-10 华柏恩视觉研究中心 用于预防和治疗接触镜致乳头性结膜炎以及过敏性眼病的组合物
AR089518A1 (es) * 2012-12-27 2014-08-27 Vega Villavicencio Parsival Costra artificial porosa semipermeable
PT2898888T (pt) * 2014-01-22 2019-07-16 Visufarma B V Composição que compreende iota-carragenina contra conjuntivite viral
BR112017002356A2 (pt) * 2014-08-08 2017-11-28 Shanghai Hightide Biopharmaceutical Ltd composições de formulação líquida, dispositivos de entrega de medicamento e métodos para preparação e uso dos mesmos
RS60926B1 (sr) * 2015-03-26 2020-11-30 Dmg Italia Srl Oftalmološka kompozicija za zaštitu rožnjače
EP3496516B1 (en) 2017-12-11 2020-02-19 Ion Beam Applications S.A. Superconductor cyclotron regenerator
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3827818A1 (en) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition
CN117771160A (zh) * 2022-09-22 2024-03-29 上海昊海生物科技股份有限公司 一种新型盐酸羟甲唑啉即型眼用凝胶及其制备方法
WO2025253406A1 (en) * 2024-06-05 2025-12-11 Sentiss Pharma Private Limited Dexpanthenol gel forming solution and method of preparation thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050164979A1 (en) * 2001-12-12 2005-07-28 Dorothea Gross Pharmaceutical composition for ophthalmological and rhinological application
US20070027048A1 (en) * 2001-01-12 2007-02-01 Peter Schwind Lens care product containing dexpanthenol
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
WO2010056113A1 (en) * 2008-11-17 2010-05-20 Louis Johan Wagenaar Ophthalmic solutions, including contact lens care solutions and eye drops comprising carnosine, preferably in combination with dexpanthenol and/or hyaluronic acid

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211238B1 (en) * 1998-10-27 2001-04-03 Alcon Laboratories, Inc. Preservative system for topically administrable pharmaceutical compositions
RU2333742C2 (ru) * 2001-01-09 2008-09-20 Луи Йохан ВАГЕНАР Применение декспантенола в композиции для ухода за контактными линзами
US20050220742A1 (en) 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US20070243275A1 (en) 2006-04-13 2007-10-18 Gilbard Jeffrey P Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
WO2009094466A2 (en) 2008-01-22 2009-07-30 University Of Florida Research Foundation, Inc. Contact lenses for extended release of bioactive agents containing diffusion attenuators
DK2424374T3 (en) 2009-05-01 2018-05-07 Advanced Vision Res Inc Detergent compositions and methods for using the same
IT1393712B1 (it) 2009-05-13 2012-05-08 Bruschettini Srl Composizioni oftalmiche per la riepitelizzazione, la cicatrizzazione, e la disinfezione dei tessuti oculari
CN103037858A (zh) * 2010-07-02 2013-04-10 华柏恩视觉研究中心 用于预防和治疗接触镜致乳头性结膜炎以及过敏性眼病的组合物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
US20070027048A1 (en) * 2001-01-12 2007-02-01 Peter Schwind Lens care product containing dexpanthenol
US20050164979A1 (en) * 2001-12-12 2005-07-28 Dorothea Gross Pharmaceutical composition for ophthalmological and rhinological application
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
WO2010056113A1 (en) * 2008-11-17 2010-05-20 Louis Johan Wagenaar Ophthalmic solutions, including contact lens care solutions and eye drops comprising carnosine, preferably in combination with dexpanthenol and/or hyaluronic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RACZYNSKA, K ET AL, LINIKA OCZNA (2003) VOL 105, NO 3-4 PAGES 175-178 # & MEDLINE ABSTRACT NLM14552179 *

Also Published As

Publication number Publication date
CN103037858A (zh) 2013-04-10
AU2011274245A1 (en) 2013-01-10
CA2803935A1 (en) 2012-01-05
SG186782A1 (en) 2013-02-28
US20130102679A1 (en) 2013-04-25
JP2013534527A (ja) 2013-09-05
TW201206418A (en) 2012-02-16
EP2588096A1 (en) 2013-05-08
US9161923B2 (en) 2015-10-20
WO2012000055A1 (en) 2012-01-05
US20160074345A1 (en) 2016-03-17
EP2588096A4 (en) 2013-12-25

Similar Documents

Publication Publication Date Title
US9161923B2 (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
KR102600484B1 (ko) 노안의 치료를 위한 조성물 및 방법
US10780071B2 (en) Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
ES2461617T3 (es) Composiciones farmacéuticas acuosas que contienen complejos borato-polioles
ES2604816B1 (es) Composición farmacéutica de tramadol para uso oftálmico
CA2807084C (en) Preservative free brimonidine and timolol solutions
AU2016280615A1 (en) Storage stable compositions and methods for the treatment of refractive errors of the eye
US20230235247A1 (en) Contact lens compositions and methods of use thereof
WO2020061249A2 (en) Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
WO2019153019A1 (en) Formulations comprising chelators, permeation enhancers and hydroxyethyl cellulose for treating ophthalmic disorders
US20190225917A1 (en) Contact lens compositions and methods of use thereof
HK1182338A (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
US20210052582A1 (en) Methods of use and pharmaceutical compositions of a selective syk inhibitor

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired